A significant step in understanding the binding of the malaria parasite to blood cells enabled by the ExpreS 2 technology platform

August 18th, 2014 Biotech company ExpreS2ion® Biotechnologies announced the publication of the article: ‘Structure of malariainvasion protein RH5 with erythrocyte basigin and blocking antibodies’ in the high impact scientific journal Nature, with teams at the University of Oxford. The scientists have been working together since the University of Oxford took a license to ExpreS2ions’ Drosophila Schneider-2 cell-based protein production technology …